Robert Harrison

Dr. Robert Harrison

Georgia State University, Department of Computer Science, Atlanta, USA

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
YKYasuhiro Koh
Yasuhiro Koh
HNHirotomo Nakata
Hirotomo Nakata
KMKenji Maeda
Kenji Maeda
HOHiromi Ogata
Hiromi Ogata
GBGeoffrey Bilcer
Geoffrey Bilcer
HMHiroaki Mitsuya
Hiroaki Mitsuya
We designed, synthesized, and identified UIC-94017 (TMC114), a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing a 3( R ),3a( S ),6a( R )- bis -tetrahydrofuranylurethane ( bis -THF) and a sulfonamide isostere which is extremely potent against laboratory HIV-1 strains and primary clinical isolates (50% inhibitory concentration [IC 50 ], ∼0.003 μM; IC 90 , ∼0.009 μM) with minimal cytotoxicity (50% cytotoxic concentration for CD4 + MT-2 cells, 74 μM). UIC-94017 blocked the infectivity and replication of each of HIV-1 NL4-3 variants exposed to and selected for resistance to saquinavir, indinavir, nelfinavir, or ritonavir at concentrations up to 5 μM (IC 50 s, 0.003 to 0.029 μM), although it was less active against HIV-1 NL4-3 variants selected for resistance to amprenavir (IC 50 , 0.22 μM). UIC-94017 was also potent against multi-PI-resistant clinical HIV-1 variants isolated from patients who had no response to existing antiviral regimens after having received a variety of antiviral agents. Structural analyses revealed that the close contact of UIC-94017 with the main chains of the protease active-site amino acids (Asp-29 and Asp-30) is important for its potency and wide spectrum of activity against multi-PI-resistant HIV-1 variants. Considering the favorable pharmacokinetics of UIC-94017 when administered with ritonavir, the present data warrant that UIC-94017 be further developed as a potential therapeutic agent for the treatment of primary and multi-PI-resistant HIV-1 infections.

1 December 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
IWIrene T. Weber
Irene T. Weber
RHRobert Harrison
Robert Harrison
RIRenato V. Iozzo
Renato V. Iozzo
The three-dimensional structure of human decorin, a secreted proteoglycan involved in the regulation of collagen fibrillogenesis and cellular growth, has been modeled based on the crystal structure of the porcine ribonuclease inhibitor. Both proteins contain leucine-rich repeats and share 18% identical residues. This model structure of decorin has an arch shape with the single glycosaminoglycan chain and the three N-linked oligosaccharides located on the same side of the molecule. Decorin was modeled as binding to a polar sequence of collagen type I found in the d band. The inner concave surface is the appropriate size and shape to accommodate only one collagen triple helix of approximately 3 nm in length. The binding of one collagen triple helix to decorin is proposed to play a major role in the formation of the staggered arrangement of collagen molecules within the microfibrils by preventing lateral fusion of collagen molecules.

1 May 1993 in Journal of the Optical Society of America A
Verified
Journal Article
Closed access
PDF file
RHRobert Harrison
Robert Harrison
Optics InfoBase is the Optical Society's online library for flagship journals, partnered and copublished journals, and recent proceedings from OSA conferences.

1 April 2004 in Journal of Molecular Biology
Verified
Journal Article
Closed access
YTYunfeng Tie
Yunfeng Tie
PBPeter I. Boross
Peter I. Boross
YWYuan-Fang Wang
Yuan-Fang Wang
LGLaquasha Gaddis
Laquasha Gaddis
AHAzhar K. Hussain
Azhar K. Hussain
IWIrene T. Weber
Irene T. Weber

15 August 1992 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MSM Stoffel
M Stoffel
PFP Froguel
P Froguel
JTJ Takeda
J Takeda
HZH Zouali
H Zouali
NVN Vionnet
N Vionnet
SLS Lesage
S Lesage
DNA polymorphisms in the glucokinase gene have recently been shown to be tightly linked to early-onset non-insulin-dependent diabetes mellitus in approximately 80% of French families with this form of diabetes. We previously identified a nonsense mutation in exon 7 in one of these families and showed that it was the likely cause of glucose intolerance in this dominantly inherited disorder. Here we report the isolation and partial sequence of the human glucokinase gene and the identification of two missense mutations in exon 7, Thr-228----Met and Gly-261----Arg, that cosegregate with early-onset non-insulin-dependent diabetes mellitus. To assess the molecular mechanism by which mutations at these two sites may affect glucokinase activity, the crystal structure of the related yeast hexokinase B was used as a simple model for human beta-cell glucokinase. Computer-assisted modeling suggests that mutation of Thr-228 affects affinity for ATP and mutation of Gly-261 may alter glucose binding. The identification of mutations in glucokinase, a protein that plays an important role in hepatic and beta-cell glucose metabolism, indicates that early-onset non-insulin-dependent diabetes mellitus may be primarily a disorder of carbohydrate metabolism.

1 May 2002 in Protein Engineering, Design and Selection
Verified
Journal Article
Open access
PDF file
ITIvan Y Torshin
Ivan Y Torshin
IWIrene T. Weber
Irene T. Weber
RHRobert Harrison
Robert Harrison
Empirical criteria for identification of hydrogen bonds were analyzed to produce a set of geometrically consistent criteria. For a data set of 30 structures, application of a set of purely geometrical criteria, along with exclusion of abnormal backbone conformations, also excluded a common interaction of Ser/Thr side chains with Asp/Glu side chains ([ST]/[DE] pairs). These interactions were termed `bifurcated hydrogen bonds/', which implies delocalization of a positively charged hydrogen of hydroxyl between the two acceptor atoms of the carboxylic group. These `bifurcated/' interactions are among the most common packing patterns for [ST]/[DE] pairs of side chains. Therefore, the identification of hydrogen bonds cannot be based on geometrical criteria only and requires introduction of some physico-chemical criteria.